glutamic acid has been researched along with Astrocytoma, Grade IV in 67 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (4.48) | 18.2507 |
2000's | 7 (10.45) | 29.6817 |
2010's | 34 (50.75) | 24.3611 |
2020's | 23 (34.33) | 2.80 |
Authors | Studies |
---|---|
Ergül, M; Taşkıran, AŞ | 1 |
Akkulak, A; Dağdelen, DN; Diniz, G; Kahraman, DS; Oktay, E; Şenoğlu, M; Yalçın, A; Yalcin, GD | 1 |
Gunn, B; Keniry, M; Litif, C; Lopez, A; Schuenzel, E; Udawant, S | 1 |
Fujita, Y; Hashiguchi, M; Kohmura, E; Kohta, M; Maeyama, M; Nagashima, H; Nakai, T; Sasayama, T; Somiya, Y; Tanaka, H; Tanaka, K; Uozumi, Y | 1 |
Inoue, A; Kanemura, Y; Kitazawa, R; Kunieda, T; Kusakabe, K; Nakamura, Y; Nishikawa, M; Ohnishi, T; Ohtsuka, Y; Ozaki, S; Shigekawa, S; Suehiro, S; Tanaka, J; Watanabe, H; Yamashita, D; Yano, H | 1 |
Feyissa, AM; Quiñones-Hinojosa, A; Rosenfeld, SS | 1 |
Yalcin, GD; Yeşilören, E | 1 |
Gu, Z; Guan, Y; Li, Z; Liu, Y; Lyu, Y; Wang, L; Wang, X; Wang, Y; Xiong, J; Zhang, J | 1 |
Ashkan, K; Kumaria, A | 1 |
Jo, S; Kang, H; Kang, J; Kim, B; Kim, HY; Lee, H; Lee, JM; Lee, JS; Park, E; Park, J; Shin, E; Youn, B; Youn, H | 1 |
Goswami, K; Nandakumar, DN; Prasad, C; Ramaswamy, P; Srinivas, D | 1 |
Chang, YE; Deleyrolle, LP; Dyson, KA; Grippin, AJ; Hou, AY; Huang, J; Jin, L; Karachi, A; Lin, Z; Long, Y; Mitchell, DA; Na, M; Rahman, M; Sayour, EJ; Tao, H; Zhang, W | 1 |
Erisnor, G; Khan, A; Lee, KC; Pei, Z; Wang, HY | 1 |
Bagga, P; Detre, JA; Haris, M; Reddy, R; Rich, LJ; Schnall, MD; Wilson, NE | 1 |
Bao, L; Chen, Y; DeBerardinis, RJ; Hatanpaa, KJ; Luo, W; Patel, T; Shi, X; Wang, Y; Zhang, B; Zhou, M | 1 |
Biffoni, M; Buccarelli, M; Ciocca, M; Cirrone, GAP; Dini, V; Grande, S; Guidoni, L; Luciani, AM; Pallini, R; Palma, A; Ricci-Vitiani, L; Rosi, A; Viti, V | 1 |
Cseh, O; Luchman, HA; Pugh, TJ; Restall, IJ; Richards, LM; Weiss, S | 1 |
Chen, C; Hu, X; Moni, MA; Peng, S; Quinn, JMW; Rahman, MH; Rana, HK | 1 |
Geiß, C; Poschet, G; Régnier-Vigouroux, A; Ruf, W; Witzler, C | 1 |
Akkulak, A; Dagdelen, DN; Donmez Yalcin, G | 1 |
Hörnschemeyer, J; Kirschstein, T; Lange, F | 1 |
Banyas, E; Benbenishty, A; Blinder, P; David, S; Goldshmit, Y; Mayo, L; Perelroizen, R; Ruban, A; Shalom, M; Yakovchuk, A | 1 |
Beck, J; Behringer, SP; Follo, M; Garrelfs, N; Goeldner, JM; Hannibal, L; Heiland, DH; Hofmann, UG; Joseph, K; Kueckelhaus, J; Maier, JP; Pfeifer, D; Ravi, VM; Schnell, O; Sun, N; von Ehr, J; Walch, AK; Will, P | 1 |
Belcaid, Z; Brem, H; Choi, J; Ehresman, J; Huq, S; Jackson, C; Jackson, CM; Kim, T; Kim, YH; Lim, M; Mathios, D; Medikonda, R; Pant, A; Patel, K; Pennington, Z; Routkevitch, D; Saleh, L; Shah, PP; Srivastava, S; Tong, L; Tyler, B; Xia, Y | 1 |
Campomenosi, P; Cappelletti, P; Pollegioni, L; Rabattoni, V; Sacchi, S; Tallarita, E | 1 |
Bruzzone, MG; Cantini, G; Cominelli, M; Corbetta, C; Di Ianni, N; Finocchiaro, G; Patanè, M; Pellegatta, S; Pisati, F; Poliani, PL; Pollo, B; Zucca, I | 1 |
Bergner, C; Hörnschemeyer, J; Kirschstein, T; Köhling, R; Krause, BJ; Lange, F; Linnebacher, M; Mullins, CS; Porath, K; Weßlau, K | 1 |
Alessandrini, A; Corsi, L; Mescola, A | 1 |
Katoh, H; Teramoto, K | 1 |
Amos, A; Bost, J; Maroon, J; Zuccoli, G | 1 |
Carrillo, V; Dubisz, E; Gulzar, H; Mahajan, SS; Morgan, D; Yelskaya, Z | 1 |
Hirato, J; Ikota, H; Kurihara, H; Nagaishi, M; Nakazato, Y; Nobusawa, S; Ogawa, A; Okura, N; Yokoo, H | 1 |
Hayashi, Y; Miyashita, K; Nakada, M; Nobusawa, S; Sabit, H; Suzuki, SO; Tanaka, S | 1 |
Deneka-Hannemann, S; Jarosz, B; Rzeski, W; Stoma, F; Trojanowski, T; Turski, WA; Walczak, K; Zgrajka, W | 1 |
Amiridis, S; Ching, J; Kaye, AH; Morokoff, AP; O'Brien, TJ; Stylli, SS | 1 |
Bachoo, RM; Barnett, S; DeBerardinis, RJ; Foong, C; Hatanpaa, KJ; Huang, Z; Kovacs, Z; Maher, EA; Mashimo, T; Mickey, BE; Nannepaga, S; Piccirillo, SG; Pichumani, K; Singh, DK; Sirasanagandla, S; Tu, BP; Vemireddy, V | 1 |
Aida, T; Harada, T; Namekata, K; Shinagawa, R; Takeda, T; Tanaka, K; Yanagisawa, M | 1 |
Ejima, Y; Gini, B; Hosoda, K; Imahori, T; Irino, Y; Kohmura, E; Kyotani, K; Masui, K; Mischel, PS; Mizowaki, T; Nagashima, H; Sasaki, R; Sasayama, T; Satoh, N; Takata, K; Tanaka, K; Yang, H | 1 |
Blough, M; Cai, L; Cairncross, JG; Chaumeil, MM; Eriksson, P; Izquierdo-Garcia, JL; Luchman, HA; Phillips, JJ; Pieper, RO; Radoul, M; Ronen, SM; Viswanath, P; Weiss, S | 1 |
Amiridis, S; Bjorksten, AR; Ching, J; Kaye, AH; Kountouri, N; Luwor, RB; Morokoff, AP; O'Brien, TJ; Paradiso, L; Stylli, SS; Zheng, T | 1 |
Choi, J; Régnier-Vigouroux, A; Savaskan, NE; Stradmann-Bellinghausen, B; Yakubov, E | 1 |
Boillée, S; Hewett, S; Knackstedt, L; Lewerenz, J; Massie, A | 1 |
Cheng, M; Eberhart, CG; Fan, X; Glunde, K; Kahlert, UD; Koch, K; Maciaczyk, J; Marchionni, L; Raabe, EH | 1 |
Ahmed, SU; Barnett, SC; Bjerkvig, R; Chalmers, AJ; Fack, F; Gottlieb, E; Hock, AK; Keunen, O; Lindsay, SL; Lund-Johansen, M; Miletic, H; Mørkve, SH; Niclou, SP; Oudin, A; Ruppin, E; Sakariassen, PØ; Tardito, S; Wagner, A; Weinstock, A; Zheng, L | 1 |
Bacher-Stier, C; Berndt, M; Bullich, S; Chin, FT; Dinkelborg, LM; Fels, LM; Friebe, M; Gambhir, SS; Gekeler, V; Hoehne, A; Iagaru, AH; Keu, KV; Koglin, N; Kumar, M; Mittra, ES; Moon, DH; Mosci, C; Mueller, A; Schmitt-Willich, H; Stephens, AW | 1 |
Bulik, M; Jancalek, R; Kazda, T; Lakomy, R; Pospisil, P; Slampa, P; Smrcka, M | 1 |
Carro, MS; Heiland, DH; Lange, T; Mader, I; Pfeifer, D; Schlosser, P; Schwarzwald, R; Urbach, H; Vasilikos, I; Weyerbrock, A | 1 |
Ceccanti, M; Chassidim, Y; Colonnese, C; D'Elia, A; Fassler, M; Friedman, A; Inghilleri, M; Nucciarelli, V; Onesti, E; Pell, GS; Prager, O; Raccah, R; Roth, Y; Salvati, M; Santoro, A; Shahar, H; Vazana, U; Veksler, R; Zangen, A | 1 |
Maus, A; Peters, GJ | 1 |
Koster, J; Lasky, JL; Lin, HJ; Panosyan, EH | 1 |
Bjerkvig, R; Enger, PØ; Hajek, M; Jirak, D; Sykova, E; Thorsen, F; van der Kogel, A; Wang, J | 1 |
Aronica, E; Bosma, I; Broekhuizen, AJ; Cloos, J; Heimans, JJ; Kaspers, GJ; Postma, TJ; Tannous, BA; van der Valk, P; van Vuurden, DG; Würdinger, T; Yazdani, M | 1 |
da Rocha, AB; de Araújo, DR; Fedrigo, CA; Grivicich, I; Jotz, GP; Leal, LF; Regner, A; Schunemann, DP; Simon, D | 1 |
Ackermann, H; Blasel, S; Franz, K; Hattingen, E; Weidauer, S; Zanella, F | 1 |
Eloqayli, H; Haukvik, A; Melø, TM; Sonnewald, U | 1 |
Bachoo, RM; Cho, SK; Choi, C; Deberardinis, RJ; Good, LB; Hatanpaa, KJ; Jindal, A; Kapur, P; Maher, EA; Malloy, CR; Marin-Valencia, I; Mashimo, T; Mickey, B; Pascual, JM; Raisanen, J; Rakheja, D; Sun, X; Takahashi, M; Togao, O; Vemireddy, V | 1 |
Bachoo, RM; Baek, H; Cai, L; Cho, S; Deberardinis, RJ; Good, L; Hatanpaa, KJ; Maddie, M; Maher, EA; Malloy, CR; Marin-Valencia, I; Mashimo, T; Matés, JM; Mickey, BE; Pascual, JM; Rajagopalan, KN; Tu, BP; Vemireddy, V; Yang, C; Yang, XL; Zhao, Z | 1 |
Bode, J; Caballero, B; Gaitner, M; Gavish, M; Kietz, S; Kugler, W; Lakomek, M; Peʼer, Y; Veenman, L; Zeno, S | 1 |
Bjorksten, A; D'Abaco, G; Drummond, KJ; Finch, S; Kaye, AH; Morokoff, AP; O'Brien, TJ; Paradiso, L; Powell, KL; Reid, CA; Rosenthal, MA; Wong, D; Yuen, TI | 1 |
Acebes, JJ; Aguilera, C; Alonso, J; Arús, C; Gili, J; Majós, C; Serrallonga, M | 1 |
Bading, JR; Chen, X; Conti, PS; Hou, Y; Park, R; Tohme, M | 1 |
Bergenheim, AT; Henriksson, R; Ronquist, G; Roslin, M; Ungerstedt, U; Waldenström, A | 1 |
Chung, WJ; Lyons, SA; Ogunrinu, T; Sontheimer, H; Weaver, AK | 1 |
Batinić, D; Brozović, A; Buljan, D; Dubravcić, K; Jakopec, S; Karlović, D; Osmak, M; Sorić, J | 1 |
Bhakoo, KK; Florian, CL; Noble, M; Preece, NE; Williams, SR | 1 |
Baunach, S; Gerlach, M; Lan, J; Meixensberger, J; Roosen, K | 1 |
Ito, H; Mizuguchi, J; Nishi, T; Takada, E; Takahashi, M; Yoshihama, I | 1 |
8 review(s) available for glutamic acid and Astrocytoma, Grade IV
Article | Year |
---|---|
Altered glutamatergic and inflammatory pathways promote glioblastoma growth, invasion, and seizures: An overview.
Topics: Brain Neoplasms; Glioblastoma; Glioma; Glutamic Acid; Humans; Seizures; Tumor Microenvironment | 2022 |
Pathway analysis of glutamate-mediated, calcium-related signaling in glioma progression.
Topics: Animals; Brain Neoplasms; Calcium; Disease Progression; Glioblastoma; Glutamic Acid; Humans; Neurons; Nitric Oxide; Signal Transduction | 2020 |
Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy.
Topics: Animals; Anticonvulsants; Antineoplastic Agents; Brain; Brain Neoplasms; Brain Waves; Disease Progression; Epilepsy; Excitatory Amino Acid Antagonists; Glioblastoma; Glutamic Acid; Humans; Receptors, Ionotropic Glutamate; Receptors, Metabotropic Glutamate; Signal Transduction | 2021 |
Glutamate Receptors and Glioblastoma Multiforme: An Old "Route" for New Perspectives.
Topics: Animals; Biomechanical Phenomena; Cell Movement; Central Nervous System Neoplasms; Glioblastoma; Glutamic Acid; Humans; Ion Channels; Neoplasm Invasiveness; Receptors, Glutamate; Receptors, Metabotropic Glutamate; Signal Transduction | 2019 |
Restricted calorie ketogenic diet for the treatment of glioblastoma multiforme.
Topics: Animals; Brain Neoplasms; Caloric Restriction; Combined Modality Therapy; Diet, Ketogenic; Glioblastoma; Glucose; Glutamic Acid; Humans; United States | 2013 |
A novel treatment strategy for glioblastoma multiforme and glioma associated seizures: increasing glutamate uptake with PPARγ agonists.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Excitatory Amino Acid Transporter 2; Glioblastoma; Glutamic Acid; Humans; PPAR gamma; Seizures | 2015 |
Main path and byways: non-vesicular glutamate release by system xc(-) as an important modifier of glutamatergic neurotransmission.
Topics: Animals; Brain; Brain Neoplasms; Glioblastoma; Glutamic Acid; Humans; Oxidative Stress; Synaptic Transmission | 2015 |
Glutamate and α-ketoglutarate: key players in glioma metabolism.
Topics: Antimetabolites, Antineoplastic; Brain Neoplasms; Citric Acid Cycle; Gene Expression; Glioblastoma; Glutamic Acid; Humans; Isocitrate Dehydrogenase; Ketoglutaric Acids; Mutation; Neoplasm Grading; Reactive Oxygen Species | 2017 |
1 trial(s) available for glutamic acid and Astrocytoma, Grade IV
Article | Year |
---|---|
Metabolic manipulation of glioblastoma in vivo by retrograde microdialysis of L-2, 4 diaminobutyric acid (DAB).
Topics: Aged; Aminobutyrates; Antimetabolites, Antineoplastic; Brain Neoplasms; Catheters, Indwelling; Dose-Response Relationship, Drug; Female; Glioblastoma; Glutamic Acid; Glycerol; Humans; Infusions, Intralesional; Male; Microdialysis; Middle Aged; Monitoring, Ambulatory; Stereotaxic Techniques; Taurine; Treatment Outcome | 2006 |
58 other study(ies) available for glutamic acid and Astrocytoma, Grade IV
Article | Year |
---|---|
Thiamine Protects Glioblastoma Cells against Glutamate Toxicity by Suppressing Oxidative/Endoplasmic Reticulum Stress.
Topics: Animals; Cell Survival; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Glioblastoma; Glutamic Acid; Oxidative Stress; Protective Agents; Rats; Thiamine; Tumor Cells, Cultured | 2021 |
The expression of glutamate metabolism modulators in the intracranial tumors and glioblastoma cell line.
Topics: Adolescent; Adult; Aged; Astrocytes; Brain Neoplasms; Cell Line; Child; Child, Preschool; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Glioblastoma; Glutamate Dehydrogenase; Glutamate-Ammonia Ligase; Glutamic Acid; Humans; Male; Middle Aged; Mitochondrial Proteins; Neuroglia; Retrospective Studies; Sirtuins | 2022 |
PI3K Pathway Inhibition with NVP-BEZ235 Hinders Glycolytic Metabolism in Glioblastoma Multiforme Cells.
Topics: Brain Neoplasms; Cell Line, Tumor; Forkhead Box Protein O1; Gene Expression Regulation, Neoplastic; Gene Ontology; Glioblastoma; Glucose; Glutamic Acid; Glycolysis; Humans; Imidazoles; Kaplan-Meier Estimate; Lactic Acid; NAD; Phosphatidylinositol 3-Kinases; Prognosis; Protein Kinase Inhibitors; Quinolines; Signal Transduction | 2021 |
Glutamic Acid and Total Creatine as Predictive Markers for Epilepsy in Glioblastoma by Using Magnetic Resonance Spectroscopy Before Surgery.
Topics: Creatine; Epilepsy; Glioblastoma; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Quality of Life; Reproducibility of Results | 2022 |
Quantitative measurement of peritumoral concentrations of glutamate, N-acetyl aspartate, and lactate on magnetic resonance spectroscopy predicts glioblastoma-related refractory epilepsy.
Topics: Aspartic Acid; Creatine; Drug Resistant Epilepsy; Epilepsy, Temporal Lobe; Glioblastoma; Glutamic Acid; Humans; Lactic Acid; Magnetic Resonance Spectroscopy | 2022 |
The Regulation of GLT-1 Degradation Pathway by SIRT4.
Topics: Astrocytes; Excitatory Amino Acid Transporter 2; Glioblastoma; Glutamic Acid; Humans; Mitochondrial Proteins; Neurons; Proteolysis; Sirtuins; Ubiquitination | 2023 |
Nuclear Translocation of LDHA Promotes the Catabolism of BCAAs to Sustain GBM Cell Proliferation through the TxN Antioxidant Pathway.
Topics: Amino Acids, Branched-Chain; Animals; Antioxidants; Cell Proliferation; Glioblastoma; Glutamic Acid; Humans; Lactate Dehydrogenase 5; Mice; Mice, Nude; Thioredoxins | 2023 |
Novel therapeutic strategies in glioma targeting glutamatergic neurotransmission.
Topics: Anticonvulsants; Brain Neoplasms; Glioblastoma; Glioma; Glutamic Acid; Humans; Synaptic Transmission | 2023 |
Mitochondrial glutamate transporter SLC25A22 uni-directionally export glutamate for metabolic rewiring in radioresistant glioblastoma.
Topics: Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Glutamic Acid; Humans; Mitochondria; Mitochondrial Membrane Transport Proteins; Proline; Radiation Tolerance | 2023 |
Glioblastoma invasion and NMDA receptors: A novel prospect.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Cell Line, Tumor; Cell Movement; Dizocilpine Maleate; Glioblastoma; Glutamic Acid; Humans; Neoplasm Invasiveness; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Tumor Microenvironment; Up-Regulation | 2019 |
Dysregulation of Glutamate Transport Enhances Treg Function That Promotes VEGF Blockade Resistance in Glioblastoma.
Topics: Animals; Antineoplastic Agents, Immunological; Apoptosis; Bevacizumab; CD8-Positive T-Lymphocytes; Cell Proliferation; Drug Resistance, Neoplasm; Female; Glioblastoma; Glutamic Acid; Humans; Lymphocytes, Tumor-Infiltrating; Mice; Mice, Inbred C57BL; T-Lymphocytes, Regulatory; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2020 |
Topics: Animals; Brain; Brain Mapping; Cell Line, Tumor; Diagnostic Imaging; gamma-Aminobutyric Acid; Glioblastoma; Glioma; Glucose; Glutamic Acid; Glutamine; Glycolysis; Kinetics; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Rats; Staining and Labeling | 2020 |
Regulation of branched-chain amino acid metabolism by hypoxia-inducible factor in glioblastoma.
Topics: Amino Acids, Branched-Chain; Basic Helix-Loop-Helix Transcription Factors; Brain Neoplasms; Cell Hypoxia; Cell Proliferation; Cells, Cultured; CRISPR-Cas Systems; Gene Expression Regulation, Neoplastic; Gene Knockout Techniques; Glioblastoma; Glutamic Acid; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Large Neutral Amino Acid-Transporter 1; Protein Binding; Transaminases | 2021 |
Different Mechanisms Underlie the Metabolic Response of GBM Stem-Like Cells to Ionizing Radiation: Biological and MRS Studies on Effects of Photons and Carbon Ions.
Topics: Brain Neoplasms; Cell Line, Tumor; G2 Phase Cell Cycle Checkpoints; gamma-Aminobutyric Acid; Glioblastoma; Glucose; Glutamic Acid; Humans; Ions; Lactic Acid; Magnetic Resonance Spectroscopy; Neoplastic Stem Cells; Phosphocreatine; Photons; Radiation, Ionizing | 2020 |
Brain Tumor Stem Cell Dependence on Glutaminase Reveals a Metabolic Vulnerability through the Amino Acid Deprivation Response Pathway.
Topics: Amino Acids; Astrocytes; Benzeneacetamides; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Citric Acid Cycle; Excitatory Amino Acid Transporter 1; Excitatory Amino Acid Transporter 2; Glioblastoma; Glutamic Acid; Glutaminase; Humans; Neoplastic Stem Cells; Signal Transduction; Thiadiazoles | 2020 |
Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
Topics: Atlases as Topic; Brain Neoplasms; Central Nervous System; Computational Biology; Datasets as Topic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Ontology; Gene Regulatory Networks; Glioblastoma; Glutamic Acid; Humans; Kaplan-Meier Estimate; Machine Learning; Molecular Sequence Annotation; Neoplasm Proteins; Proportional Hazards Models; Signal Transduction | 2021 |
Metabolic and inflammatory reprogramming of macrophages by ONC201 translates in a pro-inflammatory environment even in presence of glioblastoma cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Energy Metabolism; Gene Expression Regulation, Neoplastic; Glioblastoma; Glutamic Acid; Humans; Imidazoles; Macrophages; Mitochondria; Pyridines; Pyrimidines; Receptors, Dopamine D2; Receptors, Dopamine D5; Signal Transduction; Transcription Factor CHOP; Tumor Microenvironment | 2021 |
The investigation of glutamate transporter 1 (GLT-1) degradation pathway in glioblastoma cells.
Topics: Brain Neoplasms; Cell Line, Tumor; Excitatory Amino Acid Transporter 2; Glioblastoma; Glutamic Acid; Humans; Proteolysis; Ubiquitin | 2021 |
Blood glutamate scavengers increase pro-apoptotic signaling and reduce metastatic melanoma growth in-vivo.
Topics: Animals; Apoptosis; Aspartate Aminotransferase, Cytoplasmic; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Therapy, Combination; Glioblastoma; Glutamic Acid; Humans; Melanoma; Mice; Mice, Inbred C57BL; Molecular Targeted Therapy; Oxaloacetic Acid; Recombinant Proteins; Signal Transduction; Tumor Microenvironment | 2021 |
Inhibition of metabotropic glutamate receptor III facilitates sensitization to alkylating chemotherapeutics in glioblastoma.
Topics: Amino Acids; Antineoplastic Agents, Alkylating; Cell Death; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glioblastoma; Glutamic Acid; Humans; Kinetics; Neoadjuvant Therapy; Receptors, Metabotropic Glutamate; Temozolomide; Tumor Microenvironment; Xanthenes | 2021 |
Synergy between glutamate modulation and anti-programmed cell death protein 1 immunotherapy for glioblastoma.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Glutamic Acid; Immunotherapy; Mice; Mice, Inbred C57BL; Tumor Microenvironment | 2022 |
Proline oxidase controls proline, glutamate, and glutamine cellular concentrations in a U87 glioblastoma cell line.
Topics: Cell Line, Tumor; Chromatography, High Pressure Liquid; Down-Regulation; Excitatory Amino Acid Transporter 1; Excitatory Amino Acid Transporter 2; Genetic Vectors; Glioblastoma; Glutamic Acid; Glutamine; Humans; Microscopy, Fluorescence; Mitochondria; Mutagenesis, Site-Directed; Proline; Proline Oxidase | 2018 |
Altered function of the glutamate-aspartate transporter GLAST, a potential therapeutic target in glioblastoma.
Topics: Amino Acid Transport System X-AG; Animals; Apoptosis; Aspartic Acid; Astrocytes; Benzopyrans; Cell Line, Tumor; Cell Membrane; Excitatory Amino Acid Transporter 1; Female; Glioblastoma; Glioma; Glutamic Acid; Humans; Mice; Mice, Inbred C57BL; Protein Transport; Sodium-Potassium-Exchanging ATPase | 2019 |
AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro.
Topics: Anticonvulsants; Antineoplastic Agents; Apoptosis; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Epilepsy; Glioblastoma; Glutamic Acid; Humans; Nitriles; Pyridones; Receptors, AMPA; Seizures; Up-Regulation; Valproic Acid | 2019 |
The cystine/glutamate antiporter xCT is a key regulator of EphA2 S897 phosphorylation under glucose-limited conditions.
Topics: Amino Acid Transport System y+; Antiporters; Cell Line, Tumor; Cell Movement; Cell Survival; Cystine; Gene Expression Regulation, Neoplastic; Glioblastoma; Glucose; Glutamic Acid; Humans; MAP Kinase Signaling System; Phosphorylation; Reactive Oxygen Species; Receptor, EphA2; Serine | 2019 |
Synergistic inhibition of survival, proliferation, and migration of U87 cells with a combination of LY341495 and Iressa.
Topics: Amino Acids; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Gefitinib; Glioblastoma; Glutamic Acid; Humans; Quinazolines; Riluzole; Xanthenes | 2013 |
Intratumoral heterogeneity of genomic imbalance in a case of epithelioid glioblastoma with BRAF V600E mutation.
Topics: Brain Neoplasms; DNA Mutational Analysis; Glioblastoma; Glutamic Acid; Humans; Isocitrate Dehydrogenase; Male; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins B-raf; Valine; Young Adult | 2014 |
Epithelioid glioblastoma arising from pleomorphic xanthoastrocytoma with the BRAF V600E mutation.
Topics: Amino Acid Substitution; Astrocytoma; Brain Neoplasms; Child; Female; Glioblastoma; Glutamic Acid; Humans; Magnetic Resonance Imaging; Mutation; Neoplasms, Second Primary; Proto-Oncogene Proteins B-raf; Time Factors; Valine | 2014 |
Kynurenic acid inhibits proliferation and migration of human glioblastoma T98G cells.
Topics: Adult; Aged; Benzodiazepines; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Glioblastoma; Glutamic Acid; Humans; Kynurenic Acid; Male; Middle Aged | 2014 |
Acetate is a bioenergetic substrate for human glioblastoma and brain metastases.
Topics: Acetate-CoA Ligase; Acetates; Animals; Brain Neoplasms; Citric Acid Cycle; Disease Models, Animal; Glioblastoma; Glutamic Acid; Humans; Mice; Neoplasm Metastasis | 2014 |
Arundic acid attenuates retinal ganglion cell death by increasing glutamate/aspartate transporter expression in a model of normal tension glaucoma.
Topics: Animals; Caprylates; Cell Death; Excitatory Amino Acid Transporter 1; Gene Expression Regulation; Glaucoma; Glioblastoma; Glutamic Acid; Humans; Mice; Nerve Degeneration; Optic Nerve; Retinal Ganglion Cells | 2015 |
Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment.
Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzophenanthridines; Brain Neoplasms; Cell Line, Tumor; Citric Acid Cycle; Drug Resistance, Neoplasm; Drug Synergism; Energy Metabolism; Gas Chromatography-Mass Spectrometry; Glioblastoma; Glutamic Acid; Glutaminase; Glutamine; Glycolysis; Humans; Indoles; Ketoglutaric Acids; Magnetic Resonance Spectroscopy; Male; Metabolome; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Neoplasm Proteins; Protein Kinase Inhibitors; Purines; RNA, Small Interfering; Rotarod Performance Test; Signal Transduction; Temporal Lobe; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2015 |
IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism.
Topics: Astrocytes; Cell Line, Tumor; Cell Proliferation; Dichloroacetic Acid; Down-Regulation; Glioblastoma; Glutamic Acid; Glutarates; Humans; Isocitrate Dehydrogenase; Magnetic Resonance Spectroscopy; Mutation; Pyruvate Dehydrogenase Complex; Pyruvates | 2015 |
The peroxisome proliferator activated receptor gamma agonist pioglitazone increases functional expression of the glutamate transporter excitatory amino acid transporter 2 (EAAT2) in human glioblastoma cells.
Topics: Anilides; Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Excitatory Amino Acid Transporter 2; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioblastoma; Glutamate Plasma Membrane Transport Proteins; Glutamic Acid; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Neoplasm Transplantation; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; Seizures; Thiazolidinediones | 2015 |
Glioblastoma cells induce differential glutamatergic gene expressions in human tumor-associated microglia/macrophages and monocyte-derived macrophages.
Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Astrocytes; Brain Neoplasms; Calcium-Binding Proteins; CD11b Antigen; Coculture Techniques; DNA-Binding Proteins; Gene Expression Regulation; Glioblastoma; Glutamic Acid; Humans; Leukocyte Common Antigens; Macrophages; Microfilament Proteins; Microglia; Receptors, AMPA; Tumor Cells, Cultured | 2015 |
Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells.
Topics: Brain Neoplasms; Cell Line, Tumor; Cyclic S-Oxides; Glioblastoma; Glutamic Acid; Glutaminase; Homeostasis; Humans; Metabolome; Receptors, Notch; Thiadiazoles | 2016 |
Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma.
Topics: Animals; Astrocytes; Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Citric Acid Cycle; Coculture Techniques; Female; Glioblastoma; Glutamate-Ammonia Ligase; Glutamic Acid; Glutamine; Humans; Male; Mice, Inbred NOD; Mice, SCID; Models, Biological; Neoplastic Stem Cells; Nucleotides; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Transplantation, Heterologous | 2015 |
Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.
Topics: Adult; Aged; Animals; Brain Neoplasms; Case-Control Studies; Cell Line, Tumor; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glioblastoma; Glutamic Acid; Heterografts; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Tomography, X-Ray Computed; Tyrosine | 2016 |
Advanced MRI increases the diagnostic accuracy of recurrent glioblastoma: Single institution thresholds and validation of MR spectroscopy and diffusion weighted MR imaging.
Topics: Adult; Aged; Aspartic Acid; Brain Neoplasms; Choline; Cohort Studies; Diffusion Magnetic Resonance Imaging; Female; Glioblastoma; Glutamic Acid; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Spectroscopy; Male; Middle Aged; ROC Curve; Statistics, Nonparametric | 2016 |
Integrative Network-based Analysis of Magnetic Resonance Spectroscopy and Genome Wide Expression in Glioblastoma multiforme.
Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain Neoplasms; Computational Biology; Creatine; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genome-Wide Association Study; Glioblastoma; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Proteins; Neurons; Oligodendroglia; Prognosis; Prospective Studies; Survival Analysis | 2016 |
Glutamate-Mediated Blood-Brain Barrier Opening: Implications for Neuroprotection and Drug Delivery.
Topics: 4-Aminopyridine; Adult; Aged; Animals; Blood-Brain Barrier; Brain Neoplasms; Disease Models, Animal; Double-Blind Method; Female; Glioblastoma; Glutamic Acid; Humans; Male; Middle Aged; Neuroprotective Agents; Permeability; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Seizures; Stroke; Treatment Outcome | 2016 |
In search of druggable targets for GBM amino acid metabolism.
Topics: Amino Acids; Brain Neoplasms; Databases, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioblastoma; Glutamic Acid; Humans; Metabolic Networks and Pathways; Prognosis; Survival Analysis; Urea | 2017 |
Two distinct tumor phenotypes isolated from glioblastomas show different MRS characteristics.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Choline; Glioblastoma; Glutamic Acid; Magnetic Resonance Spectroscopy; Phenotype; Rats; Rats, Nude | 2008 |
Attenuated AMPA receptor expression allows glioblastoma cell survival in glutamate-rich environment.
Topics: Animals; Brain; Brain Neoplasms; Calcium; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Glioblastoma; Glutamic Acid; Humans; Immunohistochemistry; Mice; Receptors, AMPA; Sodium | 2009 |
Glutamate promotes cell growth by EGFR signaling on U-87MG human glioblastoma cell line.
Topics: Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Glioblastoma; Glutamic Acid; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Proto-Oncogene Proteins c-akt; Receptors, AMPA; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction | 2010 |
Stripe-like increase of rCBV beyond the visible border of glioblastomas: site of tumor infiltration growing after neurosurgery.
Topics: Adult; Aged; Asparagine; Blood Volume; Brain Neoplasms; Cerebrovascular Circulation; Contrast Media; Creatine; Female; Glioblastoma; Glutamic Acid; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neurosurgical Procedures; Postoperative Complications; Reproducibility of Results; Statistics, Nonparametric; Time Factors; Tritium; Young Adult | 2011 |
[2,4-(13)C]β-hydroxybutyrate metabolism in astrocytes and C6 glioblastoma cells.
Topics: 3-Hydroxybutyric Acid; Animals; Aspartic Acid; Astrocytes; Brain Neoplasms; Citric Acid Cycle; Diet, Ketogenic; Glioblastoma; Glucose; Glutamic Acid; Glutamine; Humans; Ketone Bodies; Lactic Acid; Mice; Tumor Cells, Cultured | 2011 |
Glucose metabolism via the pentose phosphate pathway, glycolysis and Krebs cycle in an orthotopic mouse model of human brain tumors.
Topics: Animals; Brain Neoplasms; Carcinoma, Renal Cell; Citric Acid Cycle; Disease Models, Animal; gamma-Aminobutyric Acid; Glioblastoma; Glucose; Glutamate Decarboxylase; Glutamic Acid; Glycolysis; Humans; Kidney Neoplasms; Lactic Acid; Magnetic Resonance Imaging; Mice; Pentose Phosphate Pathway; Positron-Emission Tomography; Xenograft Model Antitumor Assays | 2012 |
Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo.
Topics: Animals; Brain Neoplasms; Glioblastoma; Gluconeogenesis; Glucose; Glutamate-Ammonia Ligase; Glutamic Acid; Glutaminase; Glutamine; Glycolysis; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Mitochondria; Neoplasm Transplantation; Neostriatum; Oxidation-Reduction; Phenotype; Pyruvate Carboxylase; Statistics, Nonparametric; Tumor Cells, Cultured | 2012 |
Effects of 18-kDa translocator protein knockdown on gene expression of glutamate receptors, transporters, and metabolism, and on cell viability affected by glutamate.
Topics: Animals; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glioblastoma; Glutamic Acid; Humans; Oligonucleotide Array Sequence Analysis; Rats; Receptors, GABA; Receptors, Glutamate; RNA, Small Interfering | 2012 |
Glutamate is associated with a higher risk of seizures in patients with gliomas.
Topics: Adult; Amino Acid Transport System y+; Astrocytoma; Blotting, Western; Cohort Studies; Excitatory Amino Acid Transporter 1; Excitatory Amino Acid Transporter 2; Female; Glioblastoma; Glioma; Glutamate Plasma Membrane Transport Proteins; Glutamic Acid; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Retrospective Studies; Risk Factors; Seizures; Supratentorial Neoplasms; Vesicular Glutamate Transport Proteins | 2012 |
Adult primitive neuroectodermal tumor: proton MR spectroscopic findings with possible application for differential diagnosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Astrocytoma; Brain; Brain Neoplasms; Diagnosis, Differential; Female; Glioblastoma; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neuroectodermal Tumors, Primitive; Prospective Studies; Retrospective Studies | 2002 |
Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide.
Topics: Animals; Brain; Capillaries; Cells, Cultured; Dimerization; Endothelium, Vascular; Female; Fluorine Radioisotopes; Glioblastoma; Glutamic Acid; Humans; Integrin alphaVbeta3; Isotope Labeling; Kidney; Mice; Mice, Nude; Molecular Structure; Neoplasm Transplantation; Oligopeptides; Peptides, Cyclic; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards; Time Factors; Transplantation, Heterologous | 2004 |
Autocrine glutamate signaling promotes glioma cell invasion.
Topics: Amino Acid Transport System y+; Animals; Brain Neoplasms; Calcium; Cell Line, Tumor; Cell Movement; Female; Glioblastoma; Glutamic Acid; Humans; Mice; Mice, Nude; Neoplasm Invasiveness; Random Allocation; Receptors, AMPA; Signal Transduction; Sulfasalazine | 2007 |
Lithium effect on glutamate induced damage in glioblastoma cells.
Topics: Antimanic Agents; Apoptosis; Blotting, Western; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glioblastoma; Glutamic Acid; Humans; Inhibitor of Apoptosis Proteins; Lithium Chloride; Microtubule-Associated Proteins; Neoplasm Proteins; Survivin; Tumor Cells, Cultured | 2008 |
Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours.
Topics: Alanine; Amino Acids; Brain Neoplasms; Choline; Chromatography, High Pressure Liquid; Creatine; Glioblastoma; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Meningioma; Neuroblastoma; Tumor Cells, Cultured | 1995 |
Intraoperative microdialysis and tissue-pO2 measurement in human glioma.
Topics: Aspartic Acid; Brain Edema; Brain Neoplasms; Cell Death; Female; Frontal Lobe; Glioblastoma; Glutamic Acid; Humans; Male; Microdialysis; Monitoring, Intraoperative; Oxygen Consumption; Prognosis; Temporal Lobe | 1998 |
Participation of Bcl-2/Bax-alpha in glutamate-induced apoptosis of human glioblastoma cells.
Topics: Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Down-Regulation; Genetic Variation; Glioblastoma; Glutamic Acid; Humans; Osmolar Concentration; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured | 1999 |